November 20, 2020
This past November marked the first 12 months of EU-PEARL. A fruitful time in which the project Consortium has largely focused on laying the foundations to start developing the innovative IRP framework. Once in place, this new paradigm which deepens into the adaptive platform trials approach, will bring more efficacy and speed to the drug development process. An advancement that COVID-19 has revealed essential to address global health challenges. The initial steps in this inspiring journey to create state of the...
Read More

Signup to stay informed